Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone

NCT01101815 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01101815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2016
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv infections, substance abuse